Form D Explorer

Form C/A — AlphaRose Therapeutics Inc

0001665160-25-001394 · filed 2025-08-27 · via StartEngine Primary, LLC

Offering

Target
$19,998
Maximum
$4,999,999
Security type
Common Stock
Price per security
$1.3500
Deadline
Oversubscription
Accepted

Issuer

CIK
2051498
Entity
Corporation
Jurisdiction
DE
Address
1401 LAVACA STREET, #851
AUSTIN, TX 78701
Phone

Most recent fiscal year financials

Total assets
$614,498
Cash
Short-term debt
$81,098
Long-term debt
$1,151,098
Revenues
COGS
Taxes paid
Net income
$-625,253

View original on SEC EDGAR.